St. Louis, MO (January 8, 2019) – Aptimmune Biologics announces the addition of two members to the company’s management team to start the New Year. Heather Bessoff, DVM, has joined the company as chief executive officer. In her new … Read More
Kemin Industries acquires equity position in Aptimmune Biologics and creates Kemin Biologics to market Aptimmune’s Barricade™ technology in swine DES MOINES, IA/ST. LOUIS, MO (August 7, 2018) – Today Aptimmune Biologics and Kemin Industries officially announced their partnership in the … Read More
St. Louis, Mo. (January 22, 2018) – Aptimmune Biologics announces it has completed its Series B funding initiative, raising more than $6 million from several investors. This increases the combined total investment to almost $9 million, generated by the company … Read More
Swine-vaccine developer recognized as Top Company at this year’s Partnering for Growth Biotech Innovation Showcase & Forum CHAMPAIGN, Illinois (March 24, 2017) – Aptimmune Biologics was awarded this year’s Biotech Innovation Showcase’s Top Company Award at the 2017 Partnering for … Read More
CHAMPAIGN, Ill. (December 14, 2016) – The Iowa State University Veterinary Diagnostic Laboratory is teaming up with Aptimmune Biologics Inc. to develop innovative solutions to fight costly viral diseases of swine. The agreement enables Iowa State to use Aptimmune’s patented … Read More
Swine mucosal vaccine company received $100,000 in funding, plus networking, mentorship and other support CHAMPAIGN, Illinois (November 17, 2016) – Aptimmune Biologics was selected by The Yield Lab, a St. Louis-based agriculture technology business accelerator and investor, to participate in a … Read More
JAMIE JOHANSEN | AgWired | June 21, 2016 Just last year the small team raised their first round of funding and brought on CEO, Aaron Gilbertie, to help lead the company through the development, product registration and commercialization of Aptimmune’s … Read More
SwineCast | July 12, 2016 Aptimmune Biologics is bringing new intra-nasal vaccination technology to the swine industry. CEO Aaron Gilbertie discusses the company’s focus and products at World Pork Expo. Read More…
JULIE HARKER | Brownfield Ag News | September 21, 2016 A wide variety of ag innovators is asking for support at the Ag Innovations Showcase. A startup company that provides crickets for poultry feed, a tropical weather forecast provider for … Read More
Company will create new swine vaccines based on advanced mucosal technology New CEO joins the company to drive development and commercialization CHAMPAIGN, Illinois – July 7, 2015 – Aptimmune Biologics, a mucosal vaccine company developing novel swine vaccines for PRRSV … Read More